Adherence to controller therapy for chronic obstructive pulmonary disease: a review

References

• Hayes D Jr, Meyer KC. Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management. Drugs Aging 2007;24:555-72
   PubMed Web of Science ®Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance – United States, 1971–2000. MMWR Surveill Summ 2002;51:1-16
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89
   PubMed Web of Science ®Google Scholar
• What are Anticholinergic Medications? New York, NY: American Thoracic Society, 2008. Available at: http://www.thoracic.org/clinical/copd-guidelines/for-patients/what-kind-of-medications-are-there-for-copd/what-are-anticholinergic-medications.php [Last accessed 4 August 2010]
   Google Scholar
• Delea T, Hagiwara M, Dalal A, et al. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol versus other inhaled maintenance therapies. Curr Med Res Opin 2009;25:1-13
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: Global Initiative for Chronic Obstructive Lung Disease, 2009
   Google Scholar
• Julius RJ, Novitsky MA Jr, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 2009;15:34-44
   PubMed Web of Science ®Google Scholar
• Nietert PJ, Tilley BC, Zhao W, et al. Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized, controlled trial. Med Care 2009;47:32-40
   PubMed Web of Science ®Google Scholar
• Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest 2000;117(2 Suppl.):33S-7S
   PubMed Web of Science ®Google Scholar
• Sikka R, Xia F, Aubert R. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449-57
   PubMed Web of Science ®Google Scholar
• Van Grunsven P, Van Schayck C, Van Deuveren M, et al. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000;37:225-34
   PubMed Web of Science ®Google Scholar
• Tamura G, Ohta K. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Respir Med 2007;101:1895-902
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson J, Calverly P, et al. Adherence to inhaled therapy, mortality, and hospital admission in COPD. Thorax 2009;64:939-43
   PubMed Web of Science ®Google Scholar
• Bender B, Pedan A, Varasteh L. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006;118:899-904
   PubMed Web of Science ®Google Scholar
• Jung E, Pickard A, Salmon J, et al. Medication adherence and persistence in the last year of life in COPD patients. Respir Med 2009;103:525-34
   PubMed Web of Science ®Google Scholar
• Krigsman K, Nilsson J, Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiol Drug Saf 2007;16:441-8
   PubMed Web of Science ®Google Scholar
• Cramer J, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007;14:25-9
   PubMed Web of Science ®Google Scholar
• Breekveldt-Postma N, Koerselman J, Erkens J, et al. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med 2007;101:1398-405
   PubMed Web of Science ®Google Scholar
• Akazawa M, Hayflinger D, Stanford R, et al. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. Am J Manag Care 2008;14:438-48
   PubMed Web of Science ®Google Scholar
• Sugawara T, Nanjo Y, Yamazaki M, et al. Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder. J Am Geriatr Soc 2009;57:919-20
   PubMed Web of Science ®Google Scholar
• Jones R, Hyland M, Hanney K, et al. A qualitative study of compliance with medication and lifestyle modification in Chronic Obstructive Pulmonary Disease (COPD). Prim Care Respir J 2004;13:149-54
   PubMedGoogle Scholar
• Dolce J, Crisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991;99:837-41
   PubMed Web of Science ®Google Scholar
• Newman S. Inhaler treatment options in COPD. Eur Respir Rev 2005;14:102-8
   Google Scholar
• Restrepo R, Alvarez M, Wittnebel L, et al. Medication adherence issues in patients treated for COPD. Int J COPD 2008;3:371-84
   Google Scholar